Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) Induction
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if the combination of clofarabine,
cytarabine, and idarubicin can help to control Acute Myeloid Leukemia (AML) in patients who
are between the ages of 18 and 60 years old. The safety of this study drug combination will
also be studied.